tiprankstipranks
Trending News
More News >
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
Japanese Market

Wakamoto Pharmaceutical Co., Ltd. (4512) Income Statement

Compare
0 Followers

Wakamoto Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q3 2023), Wakamoto Pharmaceutical Co., Ltd.'s total revenue was ¥1.97B, a decrease of -12.47% from the same quarter last year. In Q3, Wakamoto Pharmaceutical Co., Ltd.'s net income was ¥17.26M. See Wakamoto Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 7.74B¥ 8.66B¥ 8.38B¥ 8.89B¥ 10.92B
Gross Profit
¥ 3.54B¥ 4.11B¥ 4.36B¥ 4.49B¥ 6.19B
Operating Expenses
¥ 3.74B¥ 3.97B¥ 4.37B¥ 5.24B¥ 7.19B
Depreciation and Amortization
¥ 345.45M¥ 363.65M¥ 470.08M¥ 484.31M¥ 468.19M
EBITDA
¥ 504.84M¥ 575.81M¥ 755.52M¥ -218.12M¥ -442.18M
Operating Income
¥ -195.51M¥ 141.47M¥ -13.39M¥ -754.95M¥ -996.28M
Other Income/Expenses
¥ 354.37M¥ 70.11M¥ 298.24M¥ 51.94M¥ 85.24M
Pretax Income
¥ 158.85M¥ 211.57M¥ 284.86M¥ -703.01M¥ -911.04M
Net Income
¥ 108.96M¥ 138.26M¥ 238.54M¥ -601.86M¥ -1.66B
Per Share Metrics
Basic EPS
¥ 3.14¥ 3.98¥ 6.87¥ -17.34¥ -47.73
Diluted EPS
¥ 3.14¥ 3.98¥ 6.87¥ -17.34¥ -47.73
Weighted Average Shares Outstanding
34.71M 34.71M 34.71M 34.71M 34.71M
Weighted Average Shares Outstanding (Diluted)
34.71M 34.71M 34.71M 34.71M 34.71M
Currency in JPY

Wakamoto Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis